DK0846111T3 - Syntese af optisk rene forbindelser, der er anvendelige som GARFT-inhibitorer, og deres mellemprodukter - Google Patents

Syntese af optisk rene forbindelser, der er anvendelige som GARFT-inhibitorer, og deres mellemprodukter

Info

Publication number
DK0846111T3
DK0846111T3 DK96919095T DK96919095T DK0846111T3 DK 0846111 T3 DK0846111 T3 DK 0846111T3 DK 96919095 T DK96919095 T DK 96919095T DK 96919095 T DK96919095 T DK 96919095T DK 0846111 T3 DK0846111 T3 DK 0846111T3
Authority
DK
Denmark
Prior art keywords
intermediates
optically pure
synthesis
pure compounds
compounds useful
Prior art date
Application number
DK96919095T
Other languages
English (en)
Inventor
Cynthia L Palmer
Michael D Varney
William H Romines
Original Assignee
Agouron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharma filed Critical Agouron Pharma
Application granted granted Critical
Publication of DK0846111T3 publication Critical patent/DK0846111T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D333/70—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Catalysts (AREA)
DK96919095T 1995-06-07 1996-06-07 Syntese af optisk rene forbindelser, der er anvendelige som GARFT-inhibitorer, og deres mellemprodukter DK0846111T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/472,233 US5831100A (en) 1995-06-07 1995-06-07 Syntheses of optically pure compounds useful as GARFT inhibitors and their intermediates
PCT/US1996/008953 WO1996040674A1 (en) 1995-06-07 1996-06-07 Syntheses of optically pure compounds useful as garft inhibitors and their intermediates

Publications (1)

Publication Number Publication Date
DK0846111T3 true DK0846111T3 (da) 2003-12-22

Family

ID=23874680

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96919095T DK0846111T3 (da) 1995-06-07 1996-06-07 Syntese af optisk rene forbindelser, der er anvendelige som GARFT-inhibitorer, og deres mellemprodukter

Country Status (11)

Country Link
US (2) US5831100A (da)
EP (1) EP0846111B1 (da)
JP (1) JPH11507054A (da)
AT (1) ATE248158T1 (da)
AU (1) AU6152796A (da)
CA (1) CA2224211A1 (da)
DE (1) DE69629703T2 (da)
DK (1) DK0846111T3 (da)
ES (1) ES2206580T3 (da)
PT (1) PT846111E (da)
WO (1) WO1996040674A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5831100A (en) * 1995-06-07 1998-11-03 Agouron Pharmaceuticals, Inc. Syntheses of optically pure compounds useful as GARFT inhibitors and their intermediates
WO2004113328A1 (en) * 2003-06-25 2004-12-29 Pfizer Inc. Convergent asymmetric synthesis route to produce a key intermediate towards the synthesis of a garft inhibitor
WO2004113337A1 (en) * 2003-06-25 2004-12-29 Pfizer Inc. Convergent synthesis of a garft inhibitor containing a methyl substitute thiophene core and a tetrahydropyrido`2,3-d! pyrimidine ring system and intermediates therefor

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123550A (en) * 1977-10-31 1978-10-31 Syntex (U.S.A.) Inc. Bicyclo[3.1.0]hexylethylaminocarbonyl-substituted heteroaryl cardiovascular agents
DE3222914A1 (de) * 1982-06-18 1983-12-22 Beiersdorf Ag, 2000 Hamburg Substituierte 5-phenylthio-6-amino-pyrimidinone, verfahren zu ihrer herstellung und ihre verwendung sowie diese verbindungen enthaltende zubereitungen
US4927828A (en) * 1985-03-08 1990-05-22 The Trustees Of Princeton University Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives
US5026851A (en) * 1985-03-08 1991-06-25 The Trustees Of Princeton University Pyrido[2,3-]pyrimidine derivatives
US4684653A (en) * 1985-03-08 1987-08-04 The Trustees Of Princeton University Pyrido(2,3-d)pyrimidine derivatives
ZA861235B (en) * 1985-03-08 1986-10-29 Univ Princeton Pyrido(2,3-d)pyrimidine derivatives
US4831037A (en) * 1987-04-20 1989-05-16 The Trustees Of Princeton University 4 (3H)-oxo-5,6,7,8-tetrahydropyrido-(2,3-d)pyrimidine derivatives
GB8625019D0 (en) * 1986-10-18 1986-11-19 Wellcome Found Compounds
US4988813A (en) * 1986-10-20 1991-01-29 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
FR2608155B1 (fr) * 1986-12-12 1990-09-14 Scient Tech Batimen Centre Nouveaux alcools furanniques, utilisation de ceux-ci comme polyols dans la formation de polyurethannes, polyurethannes ainsi obtenus et leur procede de preparation
US4895946A (en) * 1987-10-26 1990-01-23 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
US4871743A (en) * 1988-01-19 1989-10-03 The Trustees Of Princeton University L-glutamic acid derivatives
US4889859A (en) * 1988-02-05 1989-12-26 The Trustees Of Princeton University Pyrido[2,3-d]pyrimidine derivatives
JPH029869A (ja) * 1988-04-15 1990-01-12 Wellcome Found Ltd:The 新規化合物
US4882333A (en) * 1988-05-25 1989-11-21 The Trustess Of Princeton University N-(5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-6-yl-alkanoyl)-glutamic acid derivatives
US4882334A (en) * 1988-05-25 1989-11-21 The Trustees Of Princeton University N-(5,6,7,8-tetrahydropyrido]2,3-d]pyrimidin-6-ylethl-thineyl-and furylcarbonyl)-glutamic acid derivatives
US4871746A (en) * 1988-05-31 1989-10-03 The Trustees Of Princeton University N-[N-(tetrahydropyrido[2,3-D]pyrimidinylmethyl)-aminomethylbenzoyl]glutamic acid derivatives as neoplastic growth inhibitors
US4883799A (en) * 1988-06-29 1989-11-28 The Trustees Of Princeton University N-(4-(1-hydroxy-3-(5,6,7,8-tetrahydropyrido(2,3,-d)-pyrimidin-6-yl)prop-2-yl)benzoyl)glutamic acid derivatives
GB8823041D0 (en) * 1988-09-30 1988-11-09 Lilly Sa Organic compounds & their use as pharmaceuticals
DE3901074A1 (de) * 1989-01-16 1990-07-19 Basf Ag Thiophen-2-carbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
US4971973A (en) * 1989-05-17 1990-11-20 Burroughs Wellcome Co. Glutamic acid derivatives
US4921836A (en) * 1989-05-17 1990-05-01 Burroughs Wellcome Co. Substituted glutamic acids
US4920125A (en) * 1989-08-29 1990-04-24 The Trustees Of Princeton University L-glutamic acid derivatives
US5179123A (en) * 1989-12-18 1993-01-12 G. D. Searle & Co. LTB4 synthesis inhibitors
EP0438261A3 (en) * 1990-01-16 1992-02-26 Takeda Chemical Industries, Ltd. Condensed heterocyclic glutamic acid derivatives, their production and use
US5013738A (en) * 1990-04-18 1991-05-07 The Trustees Of Princeton University L-glutamic acid derivatives
IL99500A0 (en) * 1990-09-17 1992-08-18 Agouron Pharma Naphthalene compounds,processes for the preparation thereof and pharmaceutical compositions containing the same
US5217974A (en) * 1991-03-29 1993-06-08 Eli Lilly And Company Method for treating gar-transformylase tumors in mammals and reducing mammalian toxicity
US5223503A (en) * 1991-04-29 1993-06-29 Eli Lilly And Company 6-substituted pyrido[2,3-d]pyrimidines as antineoplastic agents
US5969136A (en) * 1992-10-15 1999-10-19 Eli Lilly And Company Cyclization for preparing antifolate compounds
PT674516E (pt) * 1992-12-16 2000-05-31 Agouron Pharma Compostos de 5-tiapirimidinona e 5-selenopirimidinona substituidos antiproliferativos
CN1046285C (zh) * 1993-01-29 1999-11-10 阿格罗尼制药公司 作为抗增殖剂的稠合杂环谷氨酸衍生物
US5594139A (en) * 1993-01-29 1997-01-14 Agouron Pharmaceuticals, Inc. Processes for preparing antiproliferative garft-inhibiting compounds
SG44827A1 (en) * 1994-07-28 1997-12-19 Agouron Pharma Compounds useful as antiproliferative agents and garft inhibitors
US5608082A (en) * 1994-07-28 1997-03-04 Agouron Pharmaceuticals, Inc. Compounds useful as antiproliferative agents and GARFT inhibitors
US5831100A (en) * 1995-06-07 1998-11-03 Agouron Pharmaceuticals, Inc. Syntheses of optically pure compounds useful as GARFT inhibitors and their intermediates

Also Published As

Publication number Publication date
PT846111E (pt) 2004-01-30
CA2224211A1 (en) 1996-12-19
DE69629703D1 (de) 2003-10-02
ATE248158T1 (de) 2003-09-15
US5981748A (en) 1999-11-09
EP0846111A1 (en) 1998-06-10
EP0846111B1 (en) 2003-08-27
AU6152796A (en) 1996-12-30
WO1996040674A1 (en) 1996-12-19
ES2206580T3 (es) 2004-05-16
DE69629703T2 (de) 2004-03-11
US5831100A (en) 1998-11-03
JPH11507054A (ja) 1999-06-22

Similar Documents

Publication Publication Date Title
CA2200707A1 (en) Novel prostaglandin synthase inhibitors
EA199900591A1 (ru) АЗОТСОДЕРЖАЩИЕ ГЕТЕРОАРОМАТИЧЕСКИЕ СОЕДИНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ ФАКТОРА Ха
EA200401157A1 (ru) N-аминоацетилпирролидин-2-карбонитрилы и их применение в качестве ингибиторов ddp-iv
WO2004103977A3 (en) Process for the preparation of pyrimidine derivatives
MX9402950A (es) Piridil-3-carbinoles 4-substituidos herbicidas.
EA200000826A1 (ru) Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы
EA200400129A1 (ru) Способ получения периндоприла, его аналогов и солей с использованием 2,5-диоксооксазолидиновых промежуточных соединений
BRPI0408160B1 (pt) Processo para o preparo de ésteres do ácido nicotínico substituído e intermediários de enamina para uso nesse processo
DK1246812T3 (da) Fremgangsmåde til fremstilling af citalopram
NO20002490L (no) FremgangsmÕte for fremstilling av 1,4-dihydropyridiner og forbindelser anvendt ved denne fremgangsmÕten
DK1404642T3 (da) Fremgangsmåde til fremstillimg af 7-amino-syn-3,5-dihydroxyheptansyrederivater, mellemprodukter derfor og fremgangsmåder til deres fremstilling
DK0846111T3 (da) Syntese af optisk rene forbindelser, der er anvendelige som GARFT-inhibitorer, og deres mellemprodukter
NO960441L (no) Benzopyraner og farmasöytiske forbindelser inneholdende dem
ES2016017A6 (es) Procedimiento para preparar derivados de acido 1,1-dioxocefem-4-carbotiolico.
SE8501988D0 (sv) Iminothiazolidine derivatives
PT84560B (pt) Processo para a preparacao de derivados dissimetricos do acido 1,4-di- -hidropiridino-3,5-dicarboxilico
ATE229000T1 (de) Verfahren zur herstellung von alpha-aminoketonen
FI962322A0 (fi) (S,S,S)-N-(1-(2-karboksi-3-(N2-mesyylilysyyliamino)propyyli)1-syklopentyylikarbonyylityrosiinin kiteinen polymorfinen muoto
DK1104409T3 (da) Fremgangsmåde til fremstilling af piperazinsyre og omdannelse deraf til N-acylerede bicykliske ringe, der indeholder N,N-bindinger, hvilke forbindelser er nyttige som mellemprodukter for caspaseinhibitorer
NO970281L (no) Fremgangsmåte for stereoselektiv fremstilling av heterobicyklisk alkohol enantiomer
DK0874807T3 (da) Fremgangsmåde til fremstilling af methoximinophenylglyoxylsyrederivater
EA200100723A1 (ru) Способ получения 1-(аминометил)циклогексилуксусной кислоты
EA200401417A1 (ru) Новые производные пиперидинилалкиламинопиридазинона, способ их получения и содержащие их фармацевтические композиции
DK1155138T3 (da) Fremgangsmåde til fremstilling af optisk aktive 3,3,3-trifluormethyl-2-alkylpropionsyrederivater
EE05326B1 (et) D-vitamiini prekursorid, meetod ja vahehendid